Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.

“As a founder, I got tired of hearing ‘this is a really interesting niche that you’ve uncovered.’ What??? And as I spoke to more and more women’s health founders, I learned I wasn’t the only one hearing this appalling narrative.” Rosy Founder & CEO Lyndsey Harper.


New femtech community-driven campaign spearheaded by Rosy’s Dr. Lyndsey Harper addresses the “Women’s Health? That’s so Niche…” prejudice many femtech founders still face today.

Egg Donor Matching Platform Tulip closes a $1.7M seed round.

Adyn raises a $2.5M seed round to develop personalized birth control.

Breast pump innovator Willow adds $26.8M in an extended Series C round to invest in product development and further expansion.

UroMems raises a $23M Series B to finish development of its implantable medical device for those suffering from urinary incontincence.

Renovia raises a $17M Series C for its pelvic health focused digital therapeutic Ieva.

Mayne Pharma received FDA approval for NEXTSTELLIS, a new oral contraceptive containing E4, the first new estrogen introduced in the U.S. in 50 years.

Chrissy Teigen has launched a campaign to support women struggling with infertility, helping them find care and dispel stigma.

Coral partners with DrugViu to address minority representation in autoimmune medicine.

Babyscripts teams up with Mississippi Public Health Institute on a new maternal health initiative.

Bonafide brings innovation to the menopause space with new non-hormonal treatments and names Dr. Alyssa Dweck as new Chief Medical Officer.

Women’s Health Biotech Daré Bioscience appoints Dr. Sophia N. Ononye-Onyia to its Board of Directors.

Want to identify the biggest trends and opportunities in women’s health innovation?

Great! Our brand new Inner Circle premium subscription is your backstage pass to women’s health innovation. Here at Femtech Insider we talk about femtech & women’s health innovation all day every day and we want YOU to benefit from our insights and network.

Joining our Inner Circle allows you to have your finger on the pulse and to identify the latest women’s health trends before others in the industry. Building a business in this space? Looking to invest? Interested in healthcare innovation? This is your competitive advantage.

In the Know

Meet the 6 Innovation Spotlight Finalists from this Week’s Fertility Innovation Summit (Femtech Insider)

The $10 Billion Business of Perimenopause (Fast Company)

A Tale of Two Pinky Gloves: A bloody share ends in a remarkable victory in Germany (Medium / Menstrual Health Hub)

The Lost Embryos (NY Times)

We Need to Chat About Our Reliance on Porn for Sex Education (Lifehacker)

Opinion: No, We Don’t Know if Vaccines Change Your Period (NY Times)

A new wave of at-home fertility brands are tackling taboos (Thingtesting)

Women and the Pandemic: Serious Damage to Work, Health and Home Demands Response (Forbes)

Celmatix: This biotech startups thinks it can delay menopause by 15 years. That would transform women’s lives. (Fortune)

Including Men in Menstruation: Trans Periods & Branding (Vulvani)

I Thought I Had My ‘Timeline’ Planned. Then Came A Pandemic, An Unexpected Pregnancy, And A Cancer Diagnosis (Elle)

Pill Panics on Instagram (Medium / Dr. Jen Gunter)

Thousands of industry experts rely on Femtech Insider to stay up to date with the latest in the world of women’s health innovation each week.

Reach out to our community of global decision makers and tell your story through a platform our readers trust. Learn more about sponsorships, job postings, corporate partnerships, and other ways to partner with us:

Who’s Hiring? 

Aavia is hiring a Software Engineer.

Legacy is looking for a Product Marketing Manager.

Ritual is hiring a Research Scientist.

Elvie is looking for a Regulatory Affairs Manager.

More Jobs

Show CommentsClose Comments

Leave a comment